Skip to main content
. 2018 May 30;25(1):1258–1265. doi: 10.1080/10717544.2018.1474972

Figure 4.

Figure 4.

(a) In vitro corneal cumulative penetration profiles of genistein/MPEG-b-PAE-g-HA micelles and genistein eye drops. (b) The numbers of neovascular lumens of control groups and micelle treatment groups, n = 5. (c) Neovascular lumens formed by control HUVECs. (d) Vascular inhibition of genistein/MPEG-b-PAE-g-HA micelles on HUVECs.